The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review

被引:18
作者
Mckenzie, Andrea [1 ]
Meshkat, Shakila [1 ]
Lui, Leanna M. W. [1 ]
Ho, Roger [5 ,6 ]
Vincenzo, Joshua D. Di [1 ,4 ]
Ceban, Felicia [1 ]
Cao, Bing [7 ]
McIntyre, Roger S. [1 ,2 ,3 ,4 ]
机构
[1] Univ Hlth Network, Mood Disorder Psychopharmacol Unit, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[4] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[5] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore
[6] Natl Univ Singapore, Inst Hlth Innovat & Technol IHealthtech, Singapore, Singapore
[7] Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing 400715, Peoples R China
基金
加拿大健康研究院;
关键词
Cognition; Executive function; Memory; Psychostimulants; Depression; Attention deficit hyperactivity disorder ADHD; QUALITY-OF-LIFE; DEFICIT/HYPERACTIVITY DISORDER; ADULT ADHD; METHYLPHENIDATE; CHILDREN; PERFORMANCE; ADOLESCENTS; INHIBITION; STIMULANTS; PREVALENCE;
D O I
10.1016/j.jpsychires.2022.03.018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad range of deficits in cognitive functions which has significant implications for quality of life. Psychostimulants are demonstrated to improve symptoms of inattention and hyperactivity/impulsivity, however, their impact on cognition remains incompletely characterized. Herein, the aim of this systematic review is to synthesize the extant literature reporting on the effects of psychostimulants on cognitive function in individuals with ADHD.Method: A systematic search of PubMed, Scopus, and Web of Science from inception to July 2021 was conducted. Additional studies were identified through Google Scholar and a manual search of the reference lists of relevant articles. Inclusion criteria were original studies that evaluated the cognitive function of individuals with ADHD taking psychostimulants drugs. We assessed the quality of the included papers using the Newcastle-Ottawa scale (NOS).Results: A total of 10 studies involving 753 subjects with ADHD and 194 healthy controls were identified and eligible for inclusion. Nine studies evaluated the impact of methylphenidate on cognitive function and one study investigated the use of lisdexamfetamine. Results indicated that attentional deficits such as memory, vigilance, divided attention, phasic and tonic alertness, and focused attention were improved in ADHD patients treated with psychostimulants. The efficacy of psychostimulants in improving other domains of cognition remains inconclusive due to conflicting evidence or insignificant findings (ie. academic performance and executive function).Overall, results indicate that psychostimulants may improve only select domains of cognition (ie. memory and attention).Conclusion: Psychostimulants are reported to improve several disparate aspects of cognition among individuals with ADHD. Further research is needed to better understand the complex relationships between cognition and behavior in ADHD, as well as the impact of medication on these distinct aspects of functioning. Further research is also needed to determine whether the pro-cognitive effect of stimulants would be transferable to other mental disorders.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 39 条
  • [1] What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)
    Advokat, Claire
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2010, 34 (08) : 1256 - 1266
  • [2] Attention-Deficit/Hyperactivity disorder and behavioral inhibition: A meta-analytic review of the stop-signal paradigm
    Alderson, R. Matt
    Rapport, Mark D.
    Kofler, Michael J.
    [J]. JOURNAL OF ABNORMAL CHILD PSYCHOLOGY, 2007, 35 (05) : 745 - 758
  • [3] Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
    Aron, AR
    Dowson, JH
    Sahakian, BJ
    Robbins, TW
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 54 (12) : 1465 - 1468
  • [4] Batistela Silmara, 2016, Dement. neuropsychol., V10, P134
  • [5] Cognitive enhancers for the treatment of ADHD
    Bidwell, L. Cinnamon
    McClernon, F. Joseph
    Kollins, Scott H.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (02) : 262 - 274
  • [6] Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups
    Chung, Winston
    Jiang, Sheng-Fang
    Paksarian, Diana
    Nikolaidis, Aki
    Castellanos, F. Xavier
    Merikangas, Kathleen R.
    Milham, Michael P.
    [J]. JAMA NETWORK OPEN, 2019, 2 (11)
  • [7] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    Coghill, David R.
    Banaschewski, Tobias
    Bliss, Caleb
    Robertson, Brigitte
    Zuddas, Alessandro
    [J]. CNS DRUGS, 2018, 32 (01) : 85 - 95
  • [8] Effects of methylphenidate on memory functions of adults with ADHD
    Fuermaier, Anselm B. M.
    Tucha, Lara
    Koerts, Janneke
    Weisbrod, Matthias
    Lange, Klaus W.
    Aschenbrenner, Steffen
    Tucha, Oliver
    [J]. APPLIED NEUROPSYCHOLOGY-ADULT, 2017, 24 (03) : 199 - 211
  • [9] Executive dysfunction in medication-naive children with ADHD: A multi-modal fNIRS and EEG study
    Kaga, Yoshimi
    Ueda, Riyo
    Tanaka, Miho
    Kita, Yosuke
    Suzuki, Kota
    Okumura, Yasuko
    Egashira, Yuka
    Shirakawa, Yuka
    Mitsuhashi, Shota
    Kitamura, Yuzuki
    Nakagawa, Eiji
    Yamashita, Yushiro
    Inagaki, Masumi
    [J]. BRAIN & DEVELOPMENT, 2020, 42 (08) : 555 - 563
  • [10] Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
    Katzman, Martin A.
    Bilkey, Timothy S.
    Chokka, Pratap R.
    Fallu, Angelo
    Klassen, Larry J.
    [J]. BMC PSYCHIATRY, 2017, 17